中文 | English
Return
Total: 3122 , 1/313
Show Home Prev Next End page: GO
Author:( CHENG Yi)

1.Frontal and Parietal Alpha Asymmetry as Biomarkers for Negative Symptoms in Schizophrenia

Yao-Cheng WU ; Chih-Chung HUANG ; Yi-Guang WANG ; Chu-Ya YANG ; Wei-Chou CHANG ; Chuan-Chia CHANG ; Hsin-An CHANG

Psychiatry Investigation 2025;22(4):435-441

2.Hypoxia Exercise Mediates The miR-27/PPARγ Pathway to Improve Lipid Metabolism in Obese Rats at Target Genes and Protein Levels

Wei KONG ; Jie SHAO ; Teng ZHAI ; Qian CHENG ; Fang-Zheng HAN ; Yi QU ; Lei ZHU

Progress in Biochemistry and Biophysics 2025;52(6):1386-1400

3.Targeting effect and anti-tumor mechanism of folic acid-modified crebanine nanoparticles combined with ultra-sound irradiation on M109 cells in vitro and in vivo

Hailiang ZHANG ; Xiaoyu ZHAO ; Jiahua MEI ; Rui PAN ; Junze TANG ; Kun YU ; Rui XUE ; Xiaofei LI ; Xin CHENG

China Pharmacy 2025;36(14):1730-1736

4.Factors influencing long-term outcomes of immediate implantation in the aesthetic zone and clinical decision strategies

LI Yi ; LU Cheng ; QIU Lixin

Journal of Prevention and Treatment for Stomatological Diseases 2025;33(9):719-731

5.Relationship between stressors and job burnout: Moderating role of job well-being

Jie WU ; Fengmin CHENG ; Ruotong YI ; Weiqian YU ; Chunyan LIU ; Mengyu OU

Journal of Environmental and Occupational Medicine 2025;42(7):833-839

6.Association of physical exercise willingness and insomnia with depressive symptoms among college students

YIN Wenlong, CHAI Yehong, CHENG Tianbao, JIANG Zhihua, SUN Xiaolong, ZHANG Yi, WAN Yuhui

Chinese Journal of School Health 2025;46(8):1147-1150

7.Introduction of the main addition and revision of the Chinese Pharmacopoeia 2025 Edition(Volume Ⅱ)

ZHOU Yi ; WANG Zhijun ; YUE Zhihua ; CHENG Qilei ; YUE Ruiqi ; YANG Xi ; GUO Wei ; MA Shuangcheng

Drug Standards of China 2025;26(1):023-027

8.Interpretation and thoughts on the formulation and revision of the standards for exogenous harmful residues in traditional Chinese medicinal materials in the Chinese Pharmacopoeia 2025 Edition

WANG Ying ; SHEN Mingrui ; LIU Yuanxi ; ZUO Tiantian ; WANG Dandan ; HE Yi ; CHENG Xianlong ; JIN Hongyu ; LIU Yongli ; WEI Feng ; MA Shuangcheng

Drug Standards of China 2025;26(1):083-092

9.Progress in the application of poloxamer in new preparation technology

Xue QI ; Yi CHENG ; Nan LIU ; Zengming WANG ; Hui ZHANG ; Aiping ZHENG ; Dongzhou KANG

China Pharmacy 2025;36(5):630-635

10.Effect of Folic Acid-modified Crebanine Polyethylene Glycol-polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles Combined with Ultrasonic Irradiation on Subcutaneous Tumor Growth of Liver Cancer in Mice

Rui PAN ; Junze TANG ; Hailiang ZHANG ; Kun YU ; Xiaoyu ZHAO ; Xin CHENG

Chinese Journal of Experimental Traditional Medical Formulae 2025;31(4):217-225

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3122 , 1/313 Show Home Prev Next End page: GO